about
Comparison of low and high dose intracoronary adenosine and acetylcholine in women undergoing coronary reactivity testing: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertensionModest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training.Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)Five-year stroke rate in women with signs and symptoms of ischemia undergoing coronary angiography: a retrospective study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudyRenal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in womenExpanding the scope of practice for cardiac rehabilitation: managing patients with implantable cardioverter defibrillators.Acetylcholine versus cold pressor testing for evaluation of coronary endothelial functionEffect of Low-Furanocoumarin Hybrid Grapefruit Juice Consumption on Midazolam Pharmacokinetics.Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy.The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients.Intensive blood pressure lowering reduces adverse cardiovascular outcomes among patients with high-normal glucose: An analysis from the Systolic Blood Pressure Intervention Trial database.Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure.All-Extremity Exercise Training Improves Arterial Stiffness in Older Adults.
P50
Q33554288-BB0C0C57-6B05-4069-84D8-27C917ABFEB1Q33567530-F315616F-143B-4284-B849-793DCD21E30FQ33572992-D695DC3F-0728-430B-8392-A14F4962CB27Q33586456-63A685EB-4D85-4FB9-88EA-610CF301A37CQ33987980-473FA4A9-F8CD-45B7-BF8F-EA05B8B45B6BQ34660754-F8D27777-C340-47CA-B84E-361B10CD731BQ35061266-29BF0B89-1DDB-4C7F-A8DD-DBB6181246CBQ35214348-A8268FE1-B8FD-4DC5-A893-4A9168EBCEA6Q35249346-6A055B81-5D75-4D17-840C-48870954A611Q35581383-655F26B9-6E86-4540-9D44-495DB0B87EFCQ35721814-3101C552-A9B0-491B-9EF9-4FC3C7AD744FQ35852232-43D5C849-4BF8-4920-BE9C-E2F7E81DC67FQ36282922-35B9E18C-49E3-4246-AC56-F4AE0BA661D4Q38922421-8C8FBEE6-B796-4738-A7EA-BA12EC8E42E4Q42742266-04DB0AD5-CC3D-4435-8887-032BDECCC0B3Q46021596-363F5278-F8C2-41EA-86C4-10DA0DB037DBQ47171821-5CF44353-C6D7-4D3D-91DB-0150D67059C0Q47348124-501241F3-A6C4-4659-A2F1-2EEFE0A982E6Q50896887-6CE1128C-A1B7-46AA-98F9-6D9B3EDE8376Q51245444-4C071891-B230-45D2-AB4F-52343AF1EFB4Q52728769-BFA7B729-8EE2-4E04-A8DC-3C707362FB1EQ52912574-2F244DCC-F629-42FC-A413-67110B783F66
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eileen M Handberg
@ast
Eileen M Handberg
@en
Eileen M Handberg
@es
Eileen M Handberg
@nl
type
label
Eileen M Handberg
@ast
Eileen M Handberg
@en
Eileen M Handberg
@es
Eileen M Handberg
@nl
prefLabel
Eileen M Handberg
@ast
Eileen M Handberg
@en
Eileen M Handberg
@es
Eileen M Handberg
@nl
P108
P106
P31
P496
0000-0002-7805-9577